312 related articles for article (PubMed ID: 23826652)
1. Overview and recent developments in the medical management of paediatric uveitis.
Pilly B; Heath G; Tschuor P; Lightman S; Gale RP
Expert Opin Pharmacother; 2013 Sep; 14(13):1787-95. PubMed ID: 23826652
[TBL] [Abstract][Full Text] [Related]
2. Current therapeutic approaches to autoimmune chronic uveitis in children.
Simonini G; Cantarini L; Bresci C; Lorusso M; Galeazzi M; Cimaz R
Autoimmun Rev; 2010 Aug; 9(10):674-83. PubMed ID: 20553975
[TBL] [Abstract][Full Text] [Related]
3. Road to remission: a comprehensive review of therapy in uveitis.
Siddique SS; Shah R; Suelves AM; Foster CS
Expert Opin Investig Drugs; 2011 Nov; 20(11):1497-515. PubMed ID: 21936708
[TBL] [Abstract][Full Text] [Related]
4. TNFalpha-blocking agents or conventional immunosuppressive drugs in the therapy of children with uveitis? - an evidence based approach.
Winterhalter S; Niehues T
Klin Padiatr; 2008; 220(6):342-7. PubMed ID: 18949668
[TBL] [Abstract][Full Text] [Related]
5. Emerging drugs for the treatment of uveitis.
Leung TG; Thorne JE
Expert Opin Emerg Drugs; 2013 Dec; 18(4):513-21. PubMed ID: 24274613
[TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor-alpha blocker in treatment of juvenile idiopathic arthritis-associated uveitis refractory to second-line agents: results of a multinational survey.
Foeldvari I; Nielsen S; Kümmerle-Deschner J; Espada G; Horneff G; Bica B; Olivieri AN; Wierk A; Saurenmann RK
J Rheumatol; 2007 May; 34(5):1146-50. PubMed ID: 17343318
[TBL] [Abstract][Full Text] [Related]
7. Limited value of cyclosporine A for the treatment of patients with uveitis associated with juvenile idiopathic arthritis.
Tappeiner C; Roesel M; Heinz C; Michels H; Ganser G; Heiligenhaus A
Eye (Lond); 2009 May; 23(5):1192-8. PubMed ID: 18551142
[TBL] [Abstract][Full Text] [Related]
8. [Refractory anterior uveitis].
Labalette P
J Fr Ophtalmol; 2011 Feb; 34(2):122-6. PubMed ID: 21236513
[TBL] [Abstract][Full Text] [Related]
9. Update on the principles and novel local and systemic therapies for the treatment of non-infectious uveitis.
Gallego-Pinazo R; Dolz-Marco R; Martínez-Castillo S; Arévalo JF; Díaz-Llopis M
Inflamm Allergy Drug Targets; 2013 Feb; 12(1):38-45. PubMed ID: 23441991
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of infliximab and adalimumab for refractory uveitis in juvenile idiopathic arthritis: 1-year followup data from the Italian Registry.
Zannin ME; Birolo C; Gerloni VM; Miserocchi E; Pontikaki I; Paroli MP; Bracaglia C; Shardlow A; Parentin F; Cimaz R; Simonini G; Falcini F; Corona F; Viola S; De Marco R; Breda L; La Torre F; Vittadello F; Martini G; Zulian F
J Rheumatol; 2013 Jan; 40(1):74-9. PubMed ID: 23118110
[TBL] [Abstract][Full Text] [Related]
11. The frequency and outcome of uveitis in patients with newly diagnosed juvenile idiopathic arthritis in two 4-year cohorts from 1990-1993 and 2000-2003.
Kotaniemi K; Sihto-Kauppi K; Salomaa P; Säilä H; Ristolainen L; Kauppi M
Clin Exp Rheumatol; 2014; 32(1):143-7. PubMed ID: 24351424
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behçet's disease: an open-label trial.
Tugal-Tutkun I; Mudun A; Urgancioglu M; Kamali S; Kasapoglu E; Inanc M; Gül A
Arthritis Rheum; 2005 Aug; 52(8):2478-84. PubMed ID: 16052571
[TBL] [Abstract][Full Text] [Related]
13. Use of adalimumab in refractory non-infectious childhood chronic uveitis: efficacy in ocular disease--a case cohort interventional study.
Sen ES; Sharma S; Hinchcliffe A; Dick AD; Ramanan AV
Rheumatology (Oxford); 2012 Dec; 51(12):2199-203. PubMed ID: 22923752
[TBL] [Abstract][Full Text] [Related]
14. [Inhibitors of tumour necrosis factor-alpha for the treatment of arthritis and uveitis in childhood].
Heiligenhaus A; Horneff G; Greiner K; Mackensen F; Zierhut M; Foeldvari I; Michels H
Klin Monbl Augenheilkd; 2007 Jun; 224(6):526-31. PubMed ID: 17594625
[TBL] [Abstract][Full Text] [Related]
15. Adalimumab therapy for refractory uveitis: results of a multicentre, open-label, prospective trial.
Suhler EB; Lowder CY; Goldstein DA; Giles T; Lauer AK; Kurz PA; Pasadhika S; Lee ST; de Saint Sardos A; Butler NJ; Tessler HH; Smith JR; Rosenbaum JT
Br J Ophthalmol; 2013 Apr; 97(4):481-6. PubMed ID: 23376607
[TBL] [Abstract][Full Text] [Related]
16. Treatment of refractory uveitis with adalimumab: a prospective multicenter study of 131 patients.
Díaz-Llopis M; Salom D; Garcia-de-Vicuña C; Cordero-Coma M; Ortega G; Ortego N; Suarez-de-Figueroa M; Rio-Pardo MJ; Fernandez-Cid C; Fonollosa A; Blanco R; Garcia-Aparicio AM; Benitez-Del-Castillo JM; Olea JL; Arevalo JF
Ophthalmology; 2012 Aug; 119(8):1575-81. PubMed ID: 22525047
[TBL] [Abstract][Full Text] [Related]
17. [EBM analysis: classic DMARDs (disease-modifying antirheumatic drugs) and immunosuppressants in arthritis and uveitis].
Niehues T; Winterhalter S; Zierhut M; Michels H; Becker MD; Heiligenhaus A
Klin Monbl Augenheilkd; 2007 Jun; 224(6):520-5. PubMed ID: 17594624
[TBL] [Abstract][Full Text] [Related]
18. Abatacept in the treatment of severe, longstanding, and refractory uveitis associated with juvenile idiopathic arthritis.
Tappeiner C; Miserocchi E; Bodaghi B; Kotaniemi K; Mackensen F; Gerloni V; Quartier P; Lutz T; Heiligenhaus A
J Rheumatol; 2015 Apr; 42(4):706-11. PubMed ID: 25641892
[TBL] [Abstract][Full Text] [Related]
19. Treatment of chronic non-infectious uveitis and scleritis.
Rossi DC; Ribi C; Guex-Crosier Y
Swiss Med Wkly; 2019 Feb; 149():w20025. PubMed ID: 30852832
[TBL] [Abstract][Full Text] [Related]
20. Uveitis in juvenile idiopathic arthritis: recent therapeutic advances.
Wells JM; Smith JR
Ophthalmic Res; 2015; 54(3):124-7. PubMed ID: 26315291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
